NeuroNexus Technologies and Philips Research have announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders. The two companies aim to show the technical feasibility of highly programmable and MRI-safe deep brain stimulation devices, according to a release. Their initial research will aim to meet the functional requirements of a deep brain stimulation device for the treatment of Parkinson?s disease.